By n.luludi, 26 June, 2023 IPRP Biosimilars Working Group (BWG) Workshop - Updated The IPRP Biosimilars Working Group (BWG) is hosting a virtual workshop "Increasing the Efficiency of Biosimilar Development Programs-Reevaluating the
By n.luludi, 26 June, 2023 IPRP - 11th Meeting - Public Statement The eleventh meeting of the Management Committee (MC) of the International Pharmaceutical Regulators Programme (IPRP) was held on the 13th and 14th Ju
By n.luludi, 15 March, 2023 CTWG/GTWG - Raw Materials Reflection Paper - now published The IPRP Cell Therapy Working Group (CTWG) and Gene Therapy Working Group (GTWG) have developed the Reflection Paper on General Considerations for Raw
By n.luludi, 1 December, 2022 IPRP - 10th Meeting - Public Statement The tenth meeting of the Management Committee (MC) of the International Pharmaceutical Regulators Programme (IPRP) was held on the 16th and 17th of No
By n.leuba, 24 October, 2022 IPRP Questions and Answers document on Reliance – now published The IPRP is pleased to share a dedicated Questions and Answers document on key aspects for reliance, that was developed by the IPRP Reliance Discussio
By n.luludi, 13 June, 2022 IPRP - 9th Meeting - Public Statement The ninth meeting of the Management Committee (MC) of the International Pharmaceutical Regulators Programme (IPRP) was held on the 25th and 26th of Ma
By n.leuba, 18 February, 2022 BWG - Primer on Biosimilar-Related Regulatory Topics for Regulatory Reviewers - now published The Biosimilars Working Group (BWG) has published a Primer on Biosimilar-Related Regulatory Topics for Regulatory Reviewers. The Primer provi
By n.luludi, 6 December, 2021 IPRP - 8th Meeting - Public Statement The eighth meeting of the Management Committee (MC) of the International Pharmaceutical Regulators Programme (IPRP) was held on the 19th and 22nd of N